Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001643074-16-000003)

Filing Details

Accession Number:: 0001643074-16-000003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-14 10:11:10
Reporting Period:: 2016-03-10

Filing Date:: 2016-03-14
Accepted Time:: 2016-03-14 10:11:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636050	Axovant Sciences Ltd.	AXON	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643074	Mark Altmeyer	C/O Axovant Sciences, Inc., 320 West 37Th St. New York NY 10018	Pres&Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2016-03-10	2,300	$11.14	2,300	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported represents the weighted average price of shares acquired in multiple transactions at prices ranging from $11.10 to $11.17 per share, inclusive. The Reporting Person will provide, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares acquired at each separate price.